O, B., K, S., H, D., P, Z., W, Z., & B, M. (2024). The Double-Edged Sword of Immunotherapy-Durvalumab-Induced Polyendocrinopathy-Case Report. Journal of clinical medicine, 13(21), . https://doi.org/10.3390/jcm13216322
Chicago Style (17th ed.) CitationO, Błażowska, Stróżna K, Dancewicz H, Zygmunciak P, Zgliczyński W, and Mrozikiewicz-Rakowska B. "The Double-Edged Sword of Immunotherapy-Durvalumab-Induced Polyendocrinopathy-Case Report." Journal of Clinical Medicine 13, no. 21 (2024). https://doi.org/10.3390/jcm13216322.
MLA (9th ed.) CitationO, Błażowska, et al. "The Double-Edged Sword of Immunotherapy-Durvalumab-Induced Polyendocrinopathy-Case Report." Journal of Clinical Medicine, vol. 13, no. 21, 2024, https://doi.org/10.3390/jcm13216322.